Child Prevalence
Percentage of children with current asthma by age and state/territory
Rhode Island
NACP grantee | Age group (years) | Percentage | 95% CI |
---|---|---|---|
Total | |||
0-4 | 5.1 | (4.2 – 6.1) | |
5-9 | 10.1 | (8.9 – 11.4) | |
10-14 | 9.0 | (9.0 – 11.0) | |
15-17 | 11.3 | (10.1 – 12.7) | |
California | |||
0-4 | 2.9 | (1.9 – 4.4) | |
5-9 | 8.5 | (6.3 – 11.3) | |
10-14 | 8.1 | (6.2 – 10.6) | |
15-17 | 9.1 | (6.8 – 12.1) | |
Connecticut | |||
0-4 | 8.6 | (5.0 – 14.4) | |
5-9 | 10.1 | (7.3 – 13.6) | |
10-14 | 17.1 | (13.1 – 21.9) | |
15-17 | 10.9 | (7.7 – 15.1) | |
Florida | |||
0-4 | ND | ND | |
5-9 | ND | ND | |
10-14 | ND | ND | |
15-17 | ND | ND | |
Georgia | |||
0-4 | 7.4* | (3.4 – 15.7) | |
5-9 | 14.1 | (8.4 – 22.9) | |
10-14 | 11.6 | (7.0 – 18.5) | |
15-17 | 15.5 | (8.4 – 26.8) | |
Hawaii | |||
0-4 | 7.3* | (3.4 – 15.0) | |
5-9 | 10.1 | (6.8 – 14.8) | |
10-14 | 11.3 | (8.1 – 15.4) | |
15-17 | 13.5 | (9.5 – 18.8) | |
Illinois | |||
0-4 | 3.8* | (1.8 – 7.8) | |
5-9 | 7.9 | (4.7 – 12.9) | |
10-14 | 7.0 | (4.5 – 10.7) | |
15-17 | 13.2 | (8.6 – 19.8) | |
Indiana | |||
0-4 | 5.2* | (2.2 – 12.1) | |
5-9 | 10.6* | (5.3 – 20.2) | |
10-14 | 7.6 | (4.9 – 11.6) | |
15-17 | 9 | (5.5 – 14.5) | |
Maine | |||
0-4 | 7.8* | (4.0 – 14.7) | |
5-9 | 11.4 | (6.7 – 18.7) | |
10-14 | 10 | (6.8 – 14.6) | |
15-17 | 11 | (6.7 – 17.6) | |
Massachusetts | |||
0-4 | ** | ** | |
5-9 | 18.2 | (10.2 – 30.5) | |
10-14 | 12* | (6.5 – 21.1) | |
15-17 | 15.9 | (9.4 – 25.7) | |
Michigan | |||
0-4 | 3.6* | (1.9 – 6.6) | |
5-9 | 9.5 | (6.6 – 13.3) | |
10-14 | 10.4 | (7.9 – 13.7) | |
15-17 | 9.2 | (6.7 – 12.6) | |
Minnesota | |||
0-4 | 3.0 | (1.9 – 4.7) | |
5-9 | 6.3 | (4.3 – 9.0) | |
10-14 | 7.7 | (5.9 – 9.9) | |
15-17 | 8.7 | (6.7 – 11.3) | |
Mississippi | |||
0-4 | 10.0 | (5.7 – 16.8) | |
5-9 | 6.8 | (4.1 – 11.0) | |
10-14 | 9.8 | (6.5 – 14.5) | |
15-17 | 11.2 | (6.8 – 17.7) | |
Missouri | |||
0-4 | 2.4* | (1.1 – 5.2) | |
5-9 | 9.3 | (5.4 – 15.4) | |
10-14 | 13.1 | (9.1 – 18.5) | |
15-17 | 11.4 | (7.2 – 17.5) | |
Montana | |||
0-4 | 1.4* | (0.6 – 3.3) | |
5-9 | 7.4 | (4.0 – 13.2) | |
10-14 | 6.1 | (3.5 – 10.6) | |
15-17 | 8.8 | (4.9 – 15.1) | |
New Hampshire | |||
0-4 | ** | ** | |
5-9 | 5.2 | (3.0 – 8.7) | |
10-14 | 10.5 | (7.3 – 14.8) | |
15-17 | 9.8 | (6.3 – 14.8) | |
New Mexico | |||
0-4 | 4.2* | (2.1 – 8.3) | |
5-9 | 9.5 | (6.5 – 13.8) | |
10-14 | 14.1 | (10.0 – 19.6) | |
15-17 | 10.3 | (6.3 – 16.4) | |
New York | |||
0-4 | 7.8 | (4.5 – 13.2) | |
5-9 | 12.2 | (8.3 – 17.8) | |
10-14 | 10.3 | (6.5 – 15.9) | |
15-17 | 11.3 | (7.0 – 17.6) | |
Ohio | |||
0-4 | 3.3* | (1.6 – 6.6) | |
5-9 | 8.4* | (4.0 – 16.6) | |
10-14 | 7.5 | (4.8 – 11.5) | |
15-17 | 11.1 | (6.5 – 18.4) | |
Oregon | |||
0-4 | 4.3* | (1.8 – 9.7) | |
5-9 | 9.6 | (5.5 – 16.4) | |
10-14 | 11.1 | (7.1 – 17.0) | |
15-17 | 12.5 | (8.1 – 18.9) | |
Pennsylvania | |||
0-4 | 6.8* | (3.2 – 13.5) | |
5-9 | 12.3 | (7.8 – 19.0) | |
10-14 | 11.7 | (7.9 – 17.0) | |
15-17 | 13.3 | (8.7 – 19.9) | |
Puerto Rico | |||
0-4 | 15.2 | (10.5 – 21.5) | |
5-9 | 17.1 | (12.6 – 22.9) | |
10-14 | 25.4 | (19.6 – 32.4) | |
15-17 | 16.2 | (11.1 – 22.9) | |
0-4 | 4.4* | (1.8 – 10.0) | |
5-9 | 11.6 | (7.1 – 18.4) | |
10-14 | 14.3 | (9.9 – 20.2) | |
15-17 | 12.5 | (7.8 – 19.4) | |
Utah | |||
0-4 | 2.8 | (1.8 – 4.4) | |
5-9 | 7.0 | (5.3 – 9.2) | |
10-14 | 7.7 | (6.1 – 9.7) | |
15-17 | 11.1 | (8.2 – 14.9) | |
Vermont | |||
0-4 | 4.4* | (2.1 – 9.1) | |
5-9 | 12.3 | (8.3 – 17.8) | |
10-14 | 11.4 | (7.7 – 16.6) | |
15-17 | 13.3 | (9.2 – 18.9) | |
Wisconsin | |||
0-4 | 3.3* | (1.3 – 8.5) | |
5-9 | 8.3 | (5.1 – 13.2) | |
10-14 | 6.4* | (3.3 – 12.1) | |
15-17 | 14.1 | (9.0 – 21.5) |
Data Source: Behavioral Risk Factor Surveillance System (BRFSS), 2015
CI, Confidence interval; ND, no data.
*Relative standard error (RSE) of the estimate is 30%–50%; the estimate is unreliable.
**Relative standard error (RSE) of the estimate exceeds 50%; the estimate is suppressed.